Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Sickle Cell Trait, Vaso-Occlusive Crises, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell diseaseRecruitingPhase 32026-09-28NCT06439082

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Augusta University GeorgiaAugustaUnited States8
Childrens Hospital at MontefioreThe BronxUnited States1
Childrens National HospitalWashington D.C.United States10
Ctr for Inherited Blood DisordersOrangeUnited States1
East Carolina UniversityGreenvilleUnited States144
Norton Children s HospitalLouisvilleUnited States1
Southern Specialty ResearchFlowoodUnited States3
SpoknwrdclinicaltrialsEastonUnited States1
Texas Childrens Cancer and Hematology CenterHoustonUnited States2
The Johns Hopkins University School of MedicineBaltimoreUnited States4
Thomas Jefferson University MePhiladelphiaUnited States1
U of TX Health Science CtHoustonUnited States4
Uni of Illinois Hospital and HSCChicagoUnited States1
University of AlabamaBirminghamUnited States25
University of FloridaJacksonvilleUnited States15
Wake Forest University Baptist Medical CenterWinston-SalemUnited States11
WCG Sonar Clinical ResearchRiverdaleUnited States1